Dana-Farber Cancer Institute shared a post on LinkedIn:
“Please join us in congratulating Gordon Freeman, Professor of Medicine at Dana-Farber Cancer Institute and Harvard Medical School, and Arlene Sharpe, the Kolokotrones University Professor and chair of the Department of Immunology in the Blavatnik Institute at Harvard Medical School, who have been awarded the inaugural Gretener-Thürlemann Prize by the University of Zurich.
The two researchers have been married since 1978 and have been working together since the 1980s to better understand the immune system and the therapeutic potential of directing immune response.
“We are delighted to receive this recognition on behalf of the work of our teams and all the researchers involved,” Sharpe and Freeman said. “We are honored to be the first recipients of this important award.”
The prize, worth ~$625,000 recognizes outstanding researchers for foundational and pioneering research of societal benefit. Freeman and Sharpe were honored for decades of discoveries, some of which contributed significantly to the development of immune checkpoint inhibitors against cancer — immunotherapies that have transformed cancer treatment for millions of patients worldwide and infused newfound energy into the field.
Photo credit: Andreas Eggenberger.”
More posts about Dana-Farber Cancer Institute.